Clinical Trial: A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673744) titled 'A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)' on June 10.

Brief Summary: The primary purpose of this study is to evaluate the efficacy of ublituximab in adult participants with MG responding to treatment with efgartigimod.

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Myasthenia Gravis

Intervention: DRUG: Ublituximab

Administered as an IV infusion.

DRUG: Placebo

Administered as an IV infusion.

Recruitment Status: RECRUITING

Sponsor: TG Therapeutics, Inc.

Disclaimer: Curated by HT Sy...